Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID), 70832 [2022-25276]
Download as PDF
<![CDATA[
70832
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Persons with Respiratory Symptoms Experiencing
Homelessness.
Enrollment in Symptom Screening ..
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25242 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC,
DDID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, Deputy Director
for Infectious Diseases (BSC, DDID).
This virtual meeting is open to the
public via Zoom, limited only by the
number of web conference lines
available (500 lines). Pre-registration is
required by accessing the link below in
the addresses section.
DATES: The meeting will be held on
December 7, 2022, from 9:00 a.m. to
5:15 p.m., EST, and December 8, 2022,
from 8:30 a.m. to 1:00 p.m., EST.
ADDRESSES: Zoom virtual meeting. Preregistration is required by accessing the
link at https://cdc.zoomgov.com/
webinar/register/WN_
PbAc34lET9uD2RN8lopzig. Instructions
to access the meeting will be provided
following registration.
FOR FURTHER INFORMATION CONTACT:
Laura Hughes-Baker, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road
NE, Mailstop H24–12, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
1402; Email: LHughesBaker@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, DDID provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the CDC
Deputy Director for Infectious Diseases;
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
and the Directors of the National Center
for Emerging and Zoonotic Infectious
Diseases, the National Center for HIV,
Viral Hepatitis, STD, and TB
Prevention, and the National Center for
Immunization and Respiratory Diseases,
CDC, concerning strategies, goals, and
priorities for the programs and research
within the national centers and
monitors the overall strategic direction
and focus of DDID and the national
centers.
Matters to be Considered: The agenda
will include updates and discussions on
recent outbreaks and affected
populations, as well as brief reports
from two of the Board’s workgroups: the
Food Safety Modernization Act
Surveillance Working Group and the
Acute Flaccid Myelitis Task Force.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–25276 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity: Administration for Children
and Families Program Instruction—
Children’s Justice Act (OMB #0970–
0425)
Children’s Bureau,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
ACTION: Request for Public Comments.
AGENCY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
1,000
Number of
responses
per
respondent
Average
burden per
respons
(in hours)
1
30/60
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the ACF
Program Instruction—Children’s Justice
Act (Office of Management and Budget
(OMB) #0970–0425, expiration 6/30/
2023). There are no changes proposed to
the Program Instruction.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: The Program Instruction,
prepared in response to the enactment
of the Children’s Justice Act, Title II of
Public Law 111–320, Child Abuse
Prevention and Treatment Act
Reauthorization of 2010, provides
direction to the states and territories to
accomplish the purposes of assisting
states in developing, establishing, and
operating programs designed to
improve: (1) the assessment and
investigation of suspected child abuse
and neglect cases, including cases of
suspected child sexual abuse and
exploitation, in a manner that limits
additional trauma to the child and the
child’s family; (2) the assessment and
investigation of cases of suspected child
abuse-related fatalities and suspected
child neglect-related fatalities; (3) the
investigation and prosecution of cases of
child abuse and neglect, including child
sexual abuse and exploitation; and (4)
the assessment and investigation of
cases involving children with
disabilities or serious health-related
problems who are suspected victims of
child abuse or neglect. This Program
Instruction contains information
collection requirements that are found
in Public Law 111–320 at sections
107(b) and 107(d), and pursuant to
receiving a grant award. The
information being collected is required
by statute to be submitted pursuant to
receiving a grant award. The
SUMMARY:
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Page 70832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Deputy Director for Infectious
Diseases (BSC, DDID)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC, DDID). This virtual meeting is
open to the public via Zoom, limited only by the number of web
conference lines available (500 lines). Pre-registration is required by
accessing the link below in the addresses section.
DATES: The meeting will be held on December 7, 2022, from 9:00 a.m. to
5:15 p.m., EST, and December 8, 2022, from 8:30 a.m. to 1:00 p.m., EST.
ADDRESSES: Zoom virtual meeting. Pre-registration is required by
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_PbAc34lET9uD2RN8lopzig. Instructions to access the meeting will be
provided following registration.
FOR FURTHER INFORMATION CONTACT: Laura Hughes-Baker, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta,
Georgia 30329-4027; Telephone: (404) 639-1402; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, DDID provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director, CDC;
the CDC Deputy Director for Infectious Diseases; and the Directors of
the National Center for Emerging and Zoonotic Infectious Diseases, the
National Center for HIV, Viral Hepatitis, STD, and TB Prevention, and
the National Center for Immunization and Respiratory Diseases, CDC,
concerning strategies, goals, and priorities for the programs and
research within the national centers and monitors the overall strategic
direction and focus of DDID and the national centers.
Matters to be Considered: The agenda will include updates and
discussions on recent outbreaks and affected populations, as well as
brief reports from two of the Board's workgroups: the Food Safety
Modernization Act Surveillance Working Group and the Acute Flaccid
Myelitis Task Force. Agenda items are subject to change as priorities
dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-25276 Filed 11-18-22; 8:45 am]
BILLING CODE 4163-18-P
